Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+85.2%
5Y CAGR+37.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+85.2%/yr
vs -16.4%/yr prior
5Y CAGR
+37.6%/yr
Recent acceleration
Acceleration
+101.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $154.14M | +110.3% |
| 2024 | $73.28M | +164.8% |
| 2023 | $27.67M | +14.1% |
| 2022 | $24.25M | -36.8% |
| 2021 | $38.40M | +22.9% |
| 2020 | $31.25M | +50.3% |
| 2019 | $20.79M | -58.0% |
| 2018 | $49.53M | +18.7% |
| 2017 | $41.74M | +4.9% |
| 2016 | $39.77M | - |